Last update 01 Nov 2024

[177Lu]Lu-XT033

Overview

Basic Info

Drug Type
Small molecule drug, Therapeutic radiopharmaceuticals
Synonyms-
Target-
Mechanism
Ionising radiation emitters
Therapeutic Areas
NeoplasmsUrogenital Diseases
Active Indication
Metastatic Prostate CarcinomaMetastatic castration-resistant prostate cancerPSMA-Positive Prostatic Cancer
Inactive Indication-
Originator Organization
Sinotau Pharmaceutical GroupSinotau Pharmaceutical Group
Active Organization
Sinotau Pharmaceutical GroupSinotau Pharmaceutical Group
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with [177Lu]Lu-XT033
CTR20232375 / RecruitingPhase 1
评估[177Lu]Lu-XT033 注射液在转移性前列腺癌患者中的安全性和耐受性、辐射剂量学和药 代动力学特征以及有效性的 I/II 期临床研究
[Translation] Phase I/II clinical study to evaluate the safety and tolerability, radiation dosimetry and pharmacokinetic characteristics, and efficacy of [177Lu]Lu-XT033 injection in patients with metastatic prostate cancer
NCT06081686 / RecruitingPhase 1/2
Phase I/II Study to Evaluate the Safety and Tolerability, Radiation Dosimetry and Pharmacokinetics, and Efficacy of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer
100 Clinical Results associated with [177Lu]Lu-XT033
Login to view more data
100 Translational Medicine associated with [177Lu]Lu-XT033
Login to view more data
100 Patents (Medical) associated with [177Lu]Lu-XT033
Login to view more data
100 Deals associated with [177Lu]Lu-XT033
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Prostate CarcinomaPhase 2
CN
Sinotau Pharmaceutical GroupSinotau Pharmaceutical Group
13 Sep 2023
Metastatic castration-resistant prostate cancerPhase 1
CN
Sinotau Pharmaceutical GroupSinotau Pharmaceutical Group
13 Sep 2023
PSMA-Positive Prostatic CancerIND Approval
CN
Sinotau Pharmaceutical GroupSinotau Pharmaceutical Group
29 Dec 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free